ALKBH5 functions as a suppressor of autophagic transition, whereas cIARS hinders ferroptosis by suppressing ALKBH5-induced autophagy, thereby increasing the susceptibility to sorafenib (SF) in HCC cells [156]. The gene discussed is ALKBH5; the disease is hepatocellular carcinoma.